news
Cochrane Review Finds Cannabis Lacks Reliable Evidence for Insomnia
A new Cochrane systematic review analyzing nine clinical trials concluded that medical cannabis cannot be reliably recommended for insomnia due to poor data quality and inconsistent results. The researchers found published trials fail to show durable improvements in sleep duration or daytime alertness. It leaves clinicians without proof that dispensary tinctures offer safe, long-term sleep relief.
A new Cochrane systematic review analyzing nine clinical trials concluded that medical cannabis cannot be reliably recommended for insomnia due to poor data quality and inconsistent results. The researchers found published trials fail to show durable improvements in sleep duration or daytime alertness. It leaves clinicians without proof that dispensary tinctures offer safe, long-term sleep relief.
The architecture take
I used to tell anyone who asked that a low-dose THC gummy was harmless sleep insurance. I was wrong. This Cochrane review of nine clinical trials confirms how thin that ground actually is. People love cannabis at night because it knocks them out fast. Sedation simply suppresses conscious arousal without delivering physiological restoration. Cannabinoids bind to CB1 receptors in the central nervous system, blunting sleep latency while quietly eroding rapid eye movement and fragmenting slow-wave depth. You wake up with suppressed HRV, heavy eyes, and zero recollection of dreaming (which is usually your first warning). When researchers evaluate sleep quality, daytime cognitive alertness, or adverse events past a couple of weeks, the data falls apart. Brands built a massive dispensary pipeline on the promise that knocking your brain offline restores it. I fell for the shortcut myself. Keep sleep pressure clean with morning light and consistent wake times instead.